Healthcare -
Biotechnology - NASDAQ - US
$ 5.98
0.843 %
$ 89.7 M
Market Cap
-1.22
P/E
JSPR - COST OF REVENUE
Cost of Revenue JSPR - Jasper Therapeutics, Inc.
1.11 M
LAST VALUE
39.91%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR